human platelet aggregation function, blood flow health function
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. People aged 35-65, regardless of gender; 2. No history of allergies, no immune diseases, no obvious diseases of blood vessels or blood systems, and no abnormalities in laboratory tests (routine hematuria, liver and kidney function, blood sugar and blood lipid, coagulation function, etc.); 3. Sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Obvious vascular or hematological diseases, hypertension or infection; 2. Anyone who takes immune preparations, hormone drugs, aspirin, drugs containing aspirin, and other drugs that can change the function of platelets or the coagulation system; 3. Low platelet count (whole blood < 100 x 10^9/mL); 4. The hematocrit is lower (male < 40%, female < 37%); 5. Prothrombin time (PT) is outside of the normal reference range; 6. Abnormal hemoglobin (male < 120 g/L, female < 110 g/L); 7. Abnormal menstrual cycle, taking contraceptives or hormone replacement therapy; 8. Pregnancy; 9. Take fish oil and evening primrose oil supplement orally for one month; 10. Not suitable for venous blood collection personnel; 11. Subjects must not donate more than 560ml of blood in the month prior to entering the study; 12. allergic to tomatoes and their components; 13. Patients with gastric ulcer; 14. Surgery or trauma occurred during the test; 15. Those who took items related to the test subject's function in a short period of time affected the judgment on the result; 16. Those who did not meet the inclusion criteria, did not take the test sample as required, or the observation results were affected by the incomplete information.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Platelet aggregation rate; | — |
Countries
China
Contacts
The 983rd Hospital of the Chinese People's Liberation Army Joint Logistic Support Force